Drug Patents owned by Abbvie

1. List of Androgel drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8741881 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8729057 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8754070 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8466136 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8759329 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8486925 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8466138 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8466137 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

Drugs and Companies using TESTOSTERONE ingredient

Market Authorisation Date: 29 April, 2011

Treatment: Testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone

Dosage: GEL, METERED;TRANSDERMAL; GEL;TRANSDERMAL

More Information on Dosage

2. List of Tricor drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7320802 ABBVIE Methods of treatment using nanoparticulate fenofibrate compositions
Feb, 2023

(24 days from now)

US7276249 ABBVIE Nanoparticulate fibrate formulations
Feb, 2023

(24 days from now)

Drugs and Companies using FENOFIBRATE ingredient

Market Authorisation Date: 05 November, 2004

Treatment: Adjunctive therapy to diet in adults to reduce ldl-c, triglycerides and apo b, and increase hdl-c in patients with primary hypercholesterolemia or mixed dyslipidemia (types iia, iib) and to treat hypertriglyceridemia (types iv, v)

Dosage: TABLET;ORAL

How can I launch a generic of TRICOR before it's patent expiration?
More Information on Dosage

3. List of Trilipix drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7259186 ABBVIE Salts of fenofibric acid and pharmaceutical formulations thereof
Jan, 2025

(1 year, 11 months from now)

Drugs and Companies using CHOLINE FENOFIBRATE ingredient

Market Authorisation Date: 15 December, 2008

Treatment: NA

Dosage: CAPSULE, DELAYED RELEASE;ORAL

How can I launch a generic of TRILIPIX before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic